Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza A viruses

Journal of Virology

Volumn 89, Issue 14, 2015, Pages 7224-7234

  Liu, Wen Chun ^a   Lin, Chia Ying ^a   Tsou, Yung Ta ^a   Jan, Jia Tsrong ^b   Wu, Suh Chin ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; INFLUENZA VACCINE; VIRUS SIALIDASE; H1N1 VIRUS HEMAGGLUTININ; HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT PROTEIN; RECOMBINANT VACCINE; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; ENZYME ACTIVE SITE; HUMAN; IC50; IMMUNE RESPONSE; IMMUNIZATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N9; MOUSE; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; BACULOVIRIDAE; BAGG ALBINO MOUSE; BLOOD; DISEASE MODEL; ENZYMOLOGY; FEMALE; GENE VECTOR; GENETICS; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA A VIRUS (H5N1); INFLUENZA A VIRUS (H7N9); ORTHOMYXOVIRIDAE INFECTIONS; SF9 CELL LINE; SPODOPTERA; VIROLOGY;

HEXAPODA; INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CROSS REACTIONS; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA A VIRUS, H7N9 SUBTYPE; INFLUENZA VACCINES; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; RECOMBINANT PROTEINS; SF9 CELLS; SPODOPTERA; VACCINES, SYNTHETIC;

EID: 84931037358     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00585-15     Document Type: Article

References (36)

1. Medina RA, Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat Rev Microbiol 9:590-603. http://dx.doi.org/10.1038/nrmicro2613.
2. Zhang H, Hale BG, Xu K, Sun B. 2013. Viral and host factors required for avian H5N1 influenza A virus replication in mammalian cells. Viruses 5:1431-1446. http://dx.doi.org/10.3390/v5061431.
3. Tong S, Li Y, Rivailler P, Conrardy C, Castillo DA, Chen LM, Recuenco S, Ellison JA, Davis CT, York IA, Turmelle AS, Moran D, Rogers S, Shi M, Tao Y, Weil MR, Tang K, Rowe LA, Sammons S, Xu X, Frace M, Lindblade KA, Cox NJ, Anderson LJ, Rupprecht CE, Donis RO. 2012. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci USA 109:4269-4274. http://dx.doi.org/10.1073/pnas.1116200109.
4. Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. 2014. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol 22:183-191. http://dx.doi.org/10.1016/j.tim.2014.01.010.
5. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ. 2006. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45-49. http://dx.doi.org/10.1038/nature05114.
6. Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K, Xu X, Lu H, Zhu W, Gao Z, Xiang N, Shen Y, He Z, Gu Y, Zhang Z, Yang Y, Zhao X, Zhou L, Li X, Zou S, Zhang Y, Li X, Yang L, Guo J, Dong J, Li Q, Dong L, Zhu Y, Bai T, Wang S, Hao P, Yang W, Zhang Y, Han J, Yu H, Li D, Gao GF, Wu G, Wang Y, Yuan Z, Shu Y. 2013. Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888-1897. http://dx.doi.org/10.1056/NEJMoa1304459.
7. Kilbourne ED. 2006. Influenza pandemics of the 20th century. Emerg Infect Dis 12:9-14. http://dx.doi.org/10.3201/eid1201.051254.
8. Centers for Disease Control and Prevention. 2012. Household preparedness for public health emergencies-14 states, 2006-2010. MMWR Morb Mortal Wkly Rep 61:713-719.
9. Tweed SA, Skowronski DM, David ST, Larder A, Petric M, Lees W, Li Y, Katz J, Krajden M, Tellier R, Halpert C, Hirst M, Astell C, Lawrence D, Mak A. 2004. Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis 10:2196-2199. http://dx.doi.org/10.3201/eid1012.040961.
10. Zhang T, Bi Y, Tian H, Li X, Liu D, Wu Y, Jin T, Wang Y, Chen Q, Chen Z, Chang J, Gao GF, Xu B. 2014. Human infection with influenza virus A(H10N8) from live poultry markets, China, 2014. Emerg Infect Dis 20:2076-2079. http://dx.doi.org/10.3201/eid2012.140911.
11. Colman PM, Varghese JN, Laver WG. 1983. Structure of the catalytic and antigenic sites in influenza virus neuraminidase. Nature 303:41-44. http://dx.doi.org/10.1038/303041a0.
12. Marcelin G, Sandbulte MR, Webby RJ. 2012. Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines. RevMedVirol 22:267-279. http://dx.doi.org/10.1002/rmv.1713.
13. Ilyushina NA, Bovin NV, Webster RG. 2012. Decreased neuraminidase activity is important for the adaptation of H5N1 influenza virus to human airway epithelium. J Virol 86:4724-4733. http://dx.doi.org/10.1128/JVI.06774-11.
14. Ma W, Liu Q, Bawa B, Qiao C, Qi W, Shen H, Chen Y, Ma J, Li X, Webby RJ, Garcia-Sastre A, Richt JA. 2012. The neuraminidase and matrix genes of the 2009 pandemic influenza H1N1 virus cooperate functionally to facilitate efficient replication and transmissibility in pigs. J Gen Virol 93:1261-1268. http://dx.doi.org/10.1099/vir.0.040535-0.
15. Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD. 2004. Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol 78:12665-12667. http://dx.doi.org/10.1128/JVI.78.22.12665-12667.2004.
16. Couch RB, Kasel JA, Gerin JL, Schulman JL, Kilbourne ED. 1974. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J Infect Dis 129:411-420. http://dx.doi.org/10.1093/infdis/129.4.411.
17. Martinet W, Saelens X, Deroo T, Neirynck S, Contreras R, Min Jou W, Fiers W. 1997. Protection of mice against a lethal influenza challenge by immunization with yeast-derived recombinant influenza neuraminidase. Eur J Biochem 247:332-338. http://dx.doi.org/10.1111/j.1432-1033.1997.00332.x.
18. Johansson BE, Brett IC. 2008. Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines. Hum Vaccin 4:420-424. http://dx.doi.org/10.4161/hv.4.6.6201.
19. Bosch BJ, Bodewes R, de Vries RP, Kreijtz JH, Bartelink W, van Amerongen G, Rimmelzwaan GF, de Haan CA, Osterhaus AD, Rottier PJ. 2010. Recombinant soluble, multimericHAandNAexhibit distinctive types of protection against pandemic swine-origin 2009 A(H1N1) influenza virus infection in ferrets. J Virol 84:10366-10374. http://dx.doi.org/10.1128/JVI.01035-10.
20. Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ. 2011. A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus. PLoS One 6:e26335. http://dx.doi.org/10.1371/journal.pone.0026335.
21. Chen Z, Kim L, Subbarao K, Jin H. 2012. The 2009 pandemic H1N1 virus induces anti-neuraminidase (NA) antibodies that cross-react with the NA of H5N1 viruses in ferrets. Vaccine 30:2516-2522. http://dx.doi.org/10.1016/j.vaccine.2012.01.090.
22. Rockman S, Brown LE, Barr IG, Gilbertson B, Lowther S, Kachurin A, Kachurina O, Klippel J, Bodle J, Pearse M, Middleton D. 2013. Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine. J Virol 87:3053-3061. http://dx.doi.org/10.1128/JVI.02434-12.
23. Wu CY, Yeh YC, Chan JT, Yang YC, Yang JR, Liu MT, Wu HS, Hsiao PW. 2012. A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus. PLoS One 7:e42363. http://dx.doi.org/10.1371/journal.pone.0042363.
24. Fritz R, Sabarth N, Kiermayr S, Hohenadl C, Howard MK, Ilk R, Kistner O, Ehrlich HJ, Barrett PN, Kreil TR. 2012. A Vero cell-derived whole-virus H5N1 vaccine effectively induces neuraminidase-inhibiting antibodies. J Infect Dis 205:28-34. http://dx.doi.org/10.1093/infdis/jir711.
25. Couch RB, Atmar RL, Franco LM, Quarles JM, Wells J, Arden N, Nino D, Belmont JW. 2013. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis 207:974-981. http://dx.doi.org/10.1093/infdis/jis935.
26. Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA. 2008. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J Virol 82: 10493-10501. http://dx.doi.org/10.1128/JVI.00959-08.
27. Wei HJ, Chang W, Lin SC, Liu WC, Chang DK, Chong P, Wu SC. 2011. Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine 29:7163-7172. http://dx.doi.org/10.1016/j.vaccine.2011.05.077.
28. Lin SC, Huang MH, Tsou PC, Huang LM, Chong P, Wu SC. 2011. Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One 6:e20052. http://dx.doi.org/10.1371/journal.pone.0020052.
29. Wohlbold TJ, Nachbagauer R, Xu H, Tan GS, Hirsh A, Brokstad KA, Cox RJ, Palese P, Krammer F. 2015. Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice. mBio 6(2):e02556-14. http://dx.doi.org/10.1128/mbio.02556-14.
30. Lambre CR, Terzidis H, Greffard A, Webster RG. 1990. Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates. J Immunol Methods 135:49-57. http://dx.doi.org/10.1016/0022-1759(90)90255-T.
31. Eichelberger MC, Wan H. 2015. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 386:275-299.
32. Johansson BE, Cox MM. 2011. Influenza viral neuraminidase: the forgotten antigen. Expert Rev Vaccines 10:1683-1695. http://dx.doi.org/10.1586/erv.11.130.
33. Wu J, Zhang F, Wang M, Xu C, Song J, Zhou J, Lin X, Zhang Y, Wu X, Tan W, Lu J, Zhao H, Gao J, Zhao P, Wang Y. 2010. Characterization of neuraminidases from the highly pathogenic avian H5N1 and 2009 pandemicH1N1influenzaAviruses. PLoS One 5:e15825. http://dx.doi.org/10.1371/journal.pone.0015825.
34. Wan H, Gao J, Xu K, Chen H, Couzens LK, Rivers KH, Easterbrook JD, Yang K, Zhong L, Rajabi M, Ye J, Sultana I, Wan XF, Liu X, Perez DR, Taubenberger JK, Eichelberger MC. 2013. Molecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza viruses. J Virol 87:9290-9300. http://dx.doi.org/10.1128/JVI.01203-13.
35. Lu X, Liu F, Zeng H, Sheu T, Achenbach JE, Veguilla V, Gubareva LV, Garten R, Smith C, Yang H, Stevens J, Xu X, Katz JM, Tumpey TM. 2014. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus. Virology 454-455: 169-175. http://dx.doi.org/10.1016/j.virol.2014.02.011.
36. Doyle TM, Jaentschke B, Van Domselaar G, Hashem AM, Farnsworth A, Forbes NE, Li C, Wang J, He R, Brown EG, Li X. 2013. The universal epitope of influenza A viral neuraminidase fundamentally contributes to enzyme activity and viral replication. J Biol Chem 288:18283-18289. http://dx.doi.org/10.1074/jbc.M113.468884.